Home > Research > Publications & Outputs > Complement inhibitors for myasthenia gravis in ...

Electronic data

  • Fulltext

    Final published version, 229 KB, fulltext

    Available under license: CC BY-NC: Creative Commons Attribution-NonCommercial 4.0 International License

Links

Text available via DOI:

View graph of relations

Complement inhibitors for myasthenia gravis in adults

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published
  • Laura M White
  • Fiona J Clay
  • Anne-Marie Forbes
  • Ryan Yann Shern Keh
  • James B Lilleker
  • Jennifer Spillane
  • Karen Storms
  • Jon Sussman
  • Katherine C Dodd
Close
Article numberCD016098
<mark>Journal publication date</mark>8/07/2025
<mark>Journal</mark>Cochrane Database of Systematic Reviews
Issue number7
Volume2025
Publication StatusPublished
<mark>Original language</mark>English

Abstract

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of complement inhibitors for treating myasthenia gravis in adults compared with control treatment (placebo or standard care).